Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors

2University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany, N/A, Germany 3Medical Oncology Department, Vall d’Hebron Hospital, Barcelona, Spain 4University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany, N/A, Germany, Mologen AG, Berlin, Germany 5University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany, N/A, Germany, Mologen AG, Berlin, Germany 6University Medical Center Hamburg-Eppendorf, Hubertus-Wald University Cancer Center, Hamburg, Germany, N/A, Germany, Mologen AG, Berlin, Germany